October 28, 2021

Salk Professor Tatyana Sharpee receives ASBMB DeLano Award

索尔克新闻


Salk Professor Tatyana Sharpee receives ASBMB DeLano Award

拉霍亚—索尔克教授 塔季扬娜·沙尔佩 has won the American Society for Biochemistry and Molecular Biology’s (ASBMB) 2022 DeLano Award for Computational Biosciences. The award is given to a scientist with an innovative development or application of a computer technology that can enhance research in the life sciences at the molecular level.

Tatyana Sharpee
Tatyana Sharpee.
点击此处 用于高分辨率图像。.
版权:萨克研究所

“Tanya’s cutting-edge computational approach to neurobiology research shows exciting promise for new insights into the aging process and disease,” says Salk President 鲁斯蒂·盖奇. “We are thrilled the Society has recognized her for her groundbreaking work.”

Sharpee is the second woman to receive the Delano Award for Computational Biosciences since its inception. The award includes a plaque, a $3,000 prize and paid travel for Sharpee to present a lecture at the annual ASBMB meeting in Philadelphia, in April 2022.

Sharpee, who holds the Edwin K. Hunter Chair, studies how the brain and other biological systems work and uses information theory to quantify the activity of neurons. In one area of research, she seeks to determine how features are organized within parts of the brain that are responsible for conveying our senses, including vision, hearing and the sense of smell. Revealing the workings of these core senses could help lead to new treatments and brain-machine interfaces for patients with disruptions to these systems, which can happen as a result of stroke, dementia or with schizophrenia.

Salk Professor 托尼·亨特, who is an ASBMB member, nominated Sharpee for the award.

The DeLano Award for Computational Biosciences was established by family, friends and colleagues to honor the legacy of Warren L. DeLano, who passed away suddenly in 2009 and was best known for his computer system PyMOL, an open-source program for visualization of complex macromolecular systems.

更多信息

宣传办公室
电话:(858) 453-4100
press@salk.edu

萨尔克生物学研究所

萨尔克研究所是一个独立的非营利性研究机构,由首个安全有效的脊髓灰质炎疫苗的研发者乔纳斯·索尔克于1960年创立。该研究所的使命是推动以合作、敢于冒险为特点的基础性研究,以应对癌症、阿尔茨海默病和农业脆弱性等社会最紧迫的挑战。这项基础科学支撑着所有的转化研究,产生有助于全球新药和创新的见解。.